|
Komen EmpowerED: Breast Cancer + Menopause
Join us on Wednesday, May 27, from 1-2:30 p.m. CT for a virtual Komen EmpowerED: Education After Diagnosis event for women with breast cancer navigating menopause. Leading experts will discuss treatment-induced menopause, hormone replacement therapy (HRT), updated FDA guidance and non-hormonal options alongside survivor, Gaby Natale, who will share insights from her experience with early menopause. |
|
| | |
|
Committee Seeks to Elevate Voices, Meet Needs of People Living with MBC
Komen's MBC Steering Committee is comprised solely of people living with MBC and seeks to ensure the unique needs of the MBC community are integrated across Komen’s programs and initiatives. Recently, some new members have been added to the committee. We are so excited to welcome our newest members. Read more about them below. |
|
| | |
|
Why Join ShareForCures®?
Your breast cancer information is as unique as you are. When combined with other people in the ShareForCures community, you provide scientists with a more diverse set of data to make new discoveries, faster. |
|
| |
|
Learn with Komen – New Educational Resource - Prioritize Your Health: Breast Cancer Messages for the Native American/Indigenous Community
We’re excited to introduce a new brochure developed with guidance from the Native American community, offering culturally respectful breast health education, early detection tips and support through our Patient Care Center. Please share this resource with the Native American and Indigenous communities. Scan or click the QR code on the brochure to share feedback and help us better serve these communities. |
| | |
|
|
Real Pink Podcast – Support, Not Substitution: AI’s Role in Breast Cancer Care Listen On Demand
|
| |
|
|
Join Our ShareForCures® Info Sessions
Thursday, May 14, 2026, noon CT Register Here
Thursday, June 11, 2026, noon CT Register Here
Thursday, July 9, 2026, noon CT Register Here
Thursday, Aug. 13, 2026, noon CT Register Here
Thursday, Sept. 10, 2026, noon CT Register Here |
| |
|